SCHEMBL18725699

SCHEMBL18725699

Cc1c(Cl)cccc1-c1nccc(N)c1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.40
▸ DHODH Q02127 7/20 0.40
▸ CTSA P10619 1/20 0.39
▸ KMO O15229 1/20 0.39
▸ HAVCR2 Q8TDQ0 1/20 0.38
▸ NR4A2 P43354 1/20 0.38
▸ JAK1 P23458 1/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ TYK2 P29597 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ MT-CO2 P00403 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TTR P02766 1/20 0.36
▸ PLA2G1B P04054 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11760409 0.81 KMT2A (0.44) KMT2AALDH1A1DHODHCTSAKMO
SCHEMBL20609251 0.74 HTT (0.39) KMT2AHSD17B10LMNAHTT
SCHEMBL19138009 0.71 HTT (0.46) KMT2AALDH1A1DHODHHSD17B10MEN1
SCHEMBL20817165 0.71 KMO (0.52) ALDH1A1DHODHKMOHSD17B10CYP1A2
SCHEMBL1178513 0.69 SMN1; SMN2 (0.46) KMT2AALDH1A1KMONR4A2JAK1
SCHEMBL7018050 0.69 DPP4 (0.45) KMT2AALDH1A1DHODHHSD17B10MEN1
SCHEMBL10809139 0.69 KDM4E (0.46) KMT2AALDH1A1HSD17B10MEN1MAPT
SCHEMBL368305 0.69 DHODH (0.47) DHODHHSD17B10LMNAHTT
SCHEMBL147437 0.69 ALDH1A1 (0.52) ALDH1A1HAVCR2NR4A2JAK1HSD17B10
SCHEMBL27965143 0.68 KMT2A (0.51) KMT2AALDH1A1DHODHHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9895362-B2 Pharmaceutical composition combining an anticonvulsant and a derivate of nicotinic acid FARMACÉUTICOS RAYERE, S.A. (MX) 2018-02-20 — — US claimed
US-20170151223-A1 PHARMACEUTICAL COMPOSITION COMBINING AN ANTICONVULSANT AND A DERIVATE OF NICOTINIC ACID FARMACÉUTICOS RAYERE, S.A. (MX) 2017-06-01 — — US claimed
EP-3156051-A1 PHARMACEUTICAL COMPOSITION COMBINING AN ANTICONVULSANT AND A DERIVATE OF NICOTINIC ACID FARMACÉUTICOS RAYERE, S.A. (MX) 2017-04-19 — — EP claimed
Send feedback